Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

Disparities Data Details HIV-13 by HIV Transmission Category for 2016

Disparities Details by HIV Transmission Category for 2016
HIV-13 : Knowledge of serostatus among HIV-positive persons (percent, 13+ years)
This chart compares rates by population.

2020 Baseline (year): 82.8 (2010)
2020 Target: 90.0 2, 3
Desired Direction: ↑ Increase Desired
Data Source: National HIV Surveillance System (NHSS), CDC/NCHHSTP
Error Bar (I) represents the 95% confidence interval.
Additional footnotes may apply to these data. Please refer to footnotes below the data table for further information.
See also Disparities Overview by HIV Transmission Category for HIV-13

HIV-13 Increase the proportion of persons living with HIV who know their serostatus

Knowledge of serostatus among HIV-positive persons (percent, 13+ years)

2020 Baseline (year): 82.8 (2010)
2020 Target: 90.0 2, 3
Desired Direction: ↑ Increase Desired
Spotlight on Disparities:
HIV Transmission Category 2016 Disparity
Injection drug use, female 94.7
CI 88.6/100.0
SE
x 1.000
Best rate
Injection drug use 94.0
CI 89.7/98.8
SE
x 1.008
Injection drug use, male 93.5
CI 87.7/100.0
SE
x 1.013
Male-to-male sexual contact and injection drug use 92.3
CI 86.5/99.0
SE
x 1.026
Heterosexual contact, female 87.3
CI 84.2/90.6
SE
x 1.085
Heterosexual contact 85.5
CI 82.7/88.4
SE
x 1.108
Male-to-male sexual contact 83.6
CI 81.7/85.6
SE
x 1.133
Heterosexual contact, male 81.6
CI 76.4/87.5
SE
x 1.161
Average group rate excluding best group rate 88.3
...
SE
x 1.073
CI /

Data are subject to revision and may have changed since a previous release.

Unless noted otherwise, any age-adjusted data are adjusted using the year 2000 standard population.

Data are not available or not collected for populations not shown.

CI: 95% confidence interval.

Summary measures of health disparities by HIV Transmission Category — 2016
  • The best group rate for this objective, 94.7%, was attained by HIV-positive females who had injection drug use.
  • The worst group rate for this objective, 81.6%, was attained by HIV-positive males who had heterosexual contact.
  • The absolute difference (or range) between the best and worst group rates was 13.2 percentage points.
  • The best group rate was 1.161 times the worst group rate.
  • The best group rate was <1.100 times the average rate for all other HIV transmission category groups (excluding the best), 88.3%.
Detailed measures of health disparities by HIV Transmission Category — 2016

HIV-positive females who had injection drug use achieved the best group rate for this objective, 94.7%.

The best group rate was:

  • <1.1 times the rate among HIV-positive persons who had injection drug use.
  • <1.1 times the rate among HIV-positive males who had injection drug use.
  • <1.1 times the rate among HIV-positive males who had male-to-male sexual contact and injection drug use.
  • <1.1 times the rate among HIV-positive females who had heterosexual contact.
  • 1.108 times the rate among HIV-positive persons who had heterosexual contact.
  • 1.133 times the rate among HIV-positive males who had male-to-male sexual contact.
  • 1.161 times the rate among HIV-positive males who had heterosexual contact.
FootnotesShow Footnotes